Severe SARS-CoV-2 appears to infect coronary vessels
Oct 05, 2023
SARS-CoV-2 targets plaque macrophages, and its entry is increased in cholesterol-loaded primary macrophages.
Boar’s Head recall tied to listeria expands to 7 million more pounds of deli meat
Jul 31, 2024
“Listeria is especially harmful to people who are pregnant, aged 65 or older, or with weakened immune systems,” the FDA said.
Scientists report ‘rogue antibodies’ behind severe clotting with COVID-19
Feb 18, 2022
The study authors suggest that future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies.
Risk for diabetes after COVID-19 still increased during omicron phase
Feb 14, 2023
The risk for new-onset diabetes is significantly elevated during the omicron-dominant phase, but no increase was seen for risks for hypertension or hyperlipidemia.
FDA approves Wezlana for multiple inflammatory diseases
Nov 02, 2023
Approval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patients
Oral switch noninferior for low-risk S. Aureus bloodstream infection
Jan 26, 2024
Early oral antimicrobial therapy was noninferior to intravenous standard therapy for low-risk bloodstream infection.
Hospital-onset SARS-CoV-2 infection during omicron linked to morbidity
Jul 15, 2024
Hospital-onset SARS-CoV-2 remained associated with increased morbidity and mortality during the omicron era.
Eye ointments sold at Walmart, CVS recalled due to infection risk
Feb 27, 2024
Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.
More eye drops recalled due to infection danger
Nov 02, 2023
The new recall affects certain LEADER brand eye drops; the FDA says it found unsanitary conditions in a facility where they are manufactured.
FDA warns eye drops from major brands may cause infection
Oct 30, 2023
Twenty-six products can cause eye infection and blindness, an advisory warns.